Literature DB >> 8004772

C-CAM expression in the developing rat central nervous system.

H Sawa1, K Kamada, H Sato, S Sendo, A Kondo, I Saito, M Edlund, B Obrink.   

Abstract

C-CAM, a transmembrane glycoprotein belonging to the immunoglobulin superfamily, can mediate intercellular adhesion by homophilic, Ca(2+)-independent binding. Immunohistochemical analysis of adult rat tissues has demonstrated that C-CAM is expressed in various epithelia, vessel endothelia, and hematopoietic cells. By molecular cloning and sequence analysis several isoforms differing both in the extracellular and the cytoplasmic domains have been found. Here we have analyzed the expression of C-CAM in the developing rat central nervous system. No neuronal expression was observed, but biochemical and immunohistochemical analyses demonstrated that C-CAM becomes expressed in the microvessels from embryonic day E-13; the intensity of the staining increased through day E-15 and then gradually decreased during the perinatal and early postnatal period. The expression of C-CAM in the walls of the microvessels was confirmed by in situ hybridization. Immunoelectron microscopy showed that C-CAM was localized both to the abluminal surface of the endothelial cells and to cellular processes of primordial pericytes where these two cell types are in contact with each other. No staining was found on the luminal endothelial cell surfaces or inter-endothelial cell contact areas. During the perinatal period C-CAM also became expressed on the opposite side of the pericytes and on other cells, possibly astrocytes, in contact with these areas of the pericytes. These observations suggest that C-CAM may be involved in heterotypic, homophilic adhesion between endothelial cells, pericytes and astrocytes, and in maturation of the vessel walls.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8004772     DOI: 10.1016/0165-3806(94)90006-x

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  8 in total

1.  The murine coronavirus mouse hepatitis virus strain A59 from persistently infected murine cells exhibits an extended host range.

Authors:  J H Schickli; B D Zelus; D E Wentworth; S G Sawicki; K V Holmes
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

2.  cis Interaction of the cell adhesion molecule CEACAM1 with integrin beta(3).

Authors:  J Brümmer; A Ebrahimnejad; R Flayeh; U Schumacher; T Löning; A M Bamberger; C Wagener
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

3.  Targeted disruption of the Ceacam1 (MHVR) gene leads to reduced susceptibility of mice to mouse hepatitis virus infection.

Authors:  D M Blau; C Turbide; M Tremblay; M Olson; S Létourneau; E Michaliszyn; S Jothy; K V Holmes; N Beauchemin
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

Review 4.  The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis.

Authors:  Uwe Rueckschloss; Stefanie Kuerten; Süleyman Ergün
Journal:  Histochem Cell Biol       Date:  2016-09-30       Impact factor: 4.304

5.  Ceacam1a-/- mice are completely resistant to infection by murine coronavirus mouse hepatitis virus A59.

Authors:  Erin Hemmila; Claire Turbide; Melanie Olson; Serge Jothy; Kathryn V Holmes; Nicole Beauchemin
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain.

Authors:  Jean C Tsai; Bruce D Zelus; Kathryn V Holmes; Susan R Weiss
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

Review 7.  CEACAM1 as a multi-purpose target for cancer immunotherapy.

Authors:  Matthew Dankner; Scott D Gray-Owen; Yu-Hwa Huang; Richard S Blumberg; Nicole Beauchemin
Journal:  Oncoimmunology       Date:  2017-05-16       Impact factor: 8.110

Review 8.  CEA adhesion molecules: multifunctional proteins with signal-regulatory properties.

Authors:  B Obrink
Journal:  Curr Opin Cell Biol       Date:  1997-10       Impact factor: 8.382

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.